| |
| |
|
| Insider
Information: |
Huizinga Robert Bindert |
| Relationship: |
EVP of Research |
| City: |
Victoria |
| State: |
A1 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
69,379 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$340,651 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
69,379 |
|
|
| Total
Value |
$340,651 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aurinia Pharmaceuticals Inc |
AUPH |
EVP of Research |
2022-03-02 |
69,379 |
2021-05-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AUPH |
Aurinia Pharmaceuticals I... |
EVP of Research |
• – – |
2022-03-02 |
4 |
S |
$12.01 |
$58,236 |
D/D |
(4,849) |
69,379 |
0 |
% |
|
| AUPH |
Aurinia Pharmaceuticals I... |
EVP of Research |
• – – |
2022-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
8,500 |
74,228 |
0 |
- |
|
| AUPH |
Aurinia Pharmaceuticals I... |
EVP of Research |
• – – |
2021-10-25 |
4 |
AS |
$29.75 |
$3,867,500 |
D/D |
(130,000) |
65,728 |
0 |
% |
|
| AUPH |
Aurinia Pharmaceuticals I... |
EVP of Research |
• – – |
2021-10-25 |
4 |
OE |
$3.20 |
$304,000 |
D/D |
95,000 |
195,728 |
0 |
- |
|
| AUPH |
Aurinia Pharmaceuticals I... |
EVP of Research |
• – – |
2021-09-21 |
4 |
AS |
$23.66 |
$779,533 |
D/D |
(32,500) |
100,728 |
0 |
% |
|
| AUPH |
Aurinia Pharmaceuticals I... |
EVP of Research |
• – – |
2021-09-21 |
4 |
OE |
$2.63 |
$77,715 |
D/D |
27,136 |
133,228 |
0 |
- |
|
| AUPH |
Aurinia Pharmaceuticals I... |
EVP of Research |
• – – |
2021-09-14 |
4 |
AS |
$21.75 |
$489,375 |
D/D |
(22,500) |
106,092 |
0 |
% |
|
| AUPH |
Aurinia Pharmaceuticals I... |
EVP of Research |
• – – |
2021-09-10 |
4 |
AS |
$19.76 |
$197,950 |
D/D |
(10,000) |
128,592 |
0 |
% |
|
| AUPH |
Aurinia Pharmaceuticals I... |
EVP of Research |
• – – |
2021-09-07 |
4 |
AS |
$18.30 |
$91,500 |
D/D |
(5,000) |
138,592 |
0 |
% |
|
| AUPH |
Aurinia Pharmaceuticals I... |
Ex Vice President of Research |
• – – |
2021-05-11 |
4 |
OE |
$3.02 |
$120,800 |
D/D |
40,000 |
143,592 |
0 |
- |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
